These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 23352908)
1. Ultrasonic gene and drug delivery using eLiposomes. Javadi M; Pitt WG; Tracy CM; Barrow JR; Willardson BM; Hartley JM; Tsosie NH J Control Release; 2013 Apr; 167(1):92-100. PubMed ID: 23352908 [TBL] [Abstract][Full Text] [Related]
2. Redox-Responsive Gene Delivery from Perfluorocarbon Nanoemulsions through Cleavable Poly(2-oxazoline) Surfactants. Estabrook DA; Day RA; Sletten EM Angew Chem Int Ed Engl; 2021 Aug; 60(32):17362-17367. PubMed ID: 33930255 [TBL] [Abstract][Full Text] [Related]
7. A new electrospray method for targeted gene delivery. Boehringer S; Ruzgys P; Tamò L; Šatkauskas S; Geiser T; Gazdhar A; Hradetzky D Sci Rep; 2018 Mar; 8(1):4031. PubMed ID: 29507307 [TBL] [Abstract][Full Text] [Related]
8. Encapsulation and release of calcein from herceptin-conjugated eLiposomes. Zafar MN; Pitt WG; Husseini GA Heliyon; 2024 Mar; 10(6):e27882. PubMed ID: 38524567 [TBL] [Abstract][Full Text] [Related]
9. Fe-containing metal-organic framework with D-penicillamine for cancer-specific hydrogen peroxide generation and enhanced chemodynamic therapy. Ji HB; Kim CR; Min CH; Han JH; Kim SN; Lee C; Choy YB Bioeng Transl Med; 2023 May; 8(3):e10477. PubMed ID: 37206221 [TBL] [Abstract][Full Text] [Related]
10. Acoustically-Activated Liposomal Nanocarriers to Mitigate the Side Effects of Conventional Chemotherapy with a Focus on Emulsion-Liposomes. Zafar MN; Abuwatfa WH; Husseini GA Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839744 [TBL] [Abstract][Full Text] [Related]
11. A fluorous biphase drug delivery system triggered by low frequency ultrasound: controlled release from perfluorous discoidal porous silicon particles. Liu J; Li S; Liu L; Zhu Z Nanoscale Adv; 2020 Aug; 2(8):3561-3569. PubMed ID: 36134262 [TBL] [Abstract][Full Text] [Related]
12. Ultrasound Triggering of Liposomal Nanodrugs for Cancer Therapy: A Review. Bahutair WN; Abuwatfa WH; Husseini GA Nanomaterials (Basel); 2022 Sep; 12(17):. PubMed ID: 36080088 [TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Responsive Systems as Components for Smart Materials. Athanassiadis AG; Ma Z; Moreno-Gomez N; Melde K; Choi E; Goyal R; Fischer P Chem Rev; 2022 Mar; 122(5):5165-5208. PubMed ID: 34767350 [TBL] [Abstract][Full Text] [Related]
14. Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment. AlSawaftah N; Pitt WG; Husseini GA ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1028-1049. PubMed ID: 34151199 [TBL] [Abstract][Full Text] [Related]
15. Ultrasound-Responsive Nanocarriers in Cancer Treatment: A Review. Awad NS; Paul V; AlSawaftah NM; Ter Haar G; Allen TM; Pitt WG; Husseini GA ACS Pharmacol Transl Sci; 2021 Apr; 4(2):589-612. PubMed ID: 33860189 [TBL] [Abstract][Full Text] [Related]
16. Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms. Sun Y; Davis E Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33809633 [TBL] [Abstract][Full Text] [Related]
17. The Phospholipid Research Center: Current Research in Phospholipids and Their Use in Drug Delivery. Drescher S; van Hoogevest P Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33353254 [TBL] [Abstract][Full Text] [Related]
18. Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes. Kauscher U; Holme MN; Björnmalm M; Stevens MM Adv Drug Deliv Rev; 2019 Jan; 138():259-275. PubMed ID: 30947810 [TBL] [Abstract][Full Text] [Related]
19. State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy. Heidarli E; Dadashzadeh S; Haeri A Iran J Pharm Res; 2017; 16(4):1273-1304. PubMed ID: 29552041 [TBL] [Abstract][Full Text] [Related]